Clinical Trial Update: Freiburg ZNS-NHL Study [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial at University Hospital Freiburg is investigating primary central nervous system lymphoma, with the study status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Nervous System Lymphoma

Snippet

Sponsor: University Hospital Freiburg | Conditions: Primary Non Hodgkin Lymphoma of the Central Nervous System | Phase 2 | Status: UNKNOWN